Roivant Sciences Ltd.
USD2.75
+0.12 (+4.56%)
CEO
Matthew Gline
IPO Date
2021-09-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$2.86
Prev. Close
$2.63
Day Low
$2.63
Day High
$2.86
52W Low
$2.63
52W High
$2.86
Market Cap
$1.97B
Volume
0.04M
| 275,227 |
| $12.68 |
| 29 Dec 2023 | Ramaswamy Vivek | 10 percent owner | F-InKind | Disposed | 133,911 | $11.58 |
| 29 Dec 2023 | Ramaswamy Vivek | 10 percent owner | M-Exempt | Disposed | 251,538 | $0.00 |
| 29 Dec 2023 | Ramaswamy Vivek | 10 percent owner | M-Exempt | Disposed | 611,393 | $0.00 |
| 18 Oct 2023 | Epperly Melissa B, | director | A-Award | Acquired | 1,226 | $0.00 |
| 18 Oct 2023 | MOMTAZEE JAMES C | director | A-Award | Acquired | 1,594 | $0.00 |
| 18 Oct 2023 | MOMTAZEE JAMES C | director | J-Other | Disposed | 687 | $10.30 |
| 18 Oct 2023 | Fitzgerald Meghan | director | A-Award | Acquired | 1,269 | $0.00 |
| 2 Oct 2023 | MANCHESTER KEITH S | director | S-Sale | Disposed | 3,059,368 | $11.55 |